SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
29 hedge funds and large institutions have $48.4M invested in Sinovac Biotech, Ltd in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
18% less capital invested
Capital invested by funds: $58.8M → $48.4M (-$10.4M)
83% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 12
Holders
29
Holding in Top 10
1
Calls
$482K
Puts
$384K
Top Buyers
| 1 | +$723K | |
| 2 | +$482K | |
| 3 | +$238K | |
| 4 |
Millennium Management
New York
|
+$76K |
| 5 |
Morgan Stanley
New York
|
+$40.1K |
Top Sellers
| 1 | -$874K | |
| 2 | -$791K | |
| 3 | -$784K | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$643K |
| 5 |
SIM
Spark Investment Management
New York
|
-$197K |